362 related articles for article (PubMed ID: 30039724)
1. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
[No Abstract] [Full Text] [Related]
2. Late-onset and fast progressive neuropathy and cardiomyopathy in Val32Ala transthyretin gene mutation.
Cazzato D; Dalla Bella E; Saveri P; Taroni F; Marucci G; Lauria G
Neurol Sci; 2019 Jun; 40(6):1267-1269. PubMed ID: 30685801
[TBL] [Abstract][Full Text] [Related]
3. A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.
Nakamura Y; Yutani C; Nakazato M; Date Y; Baba T; Goto Y
Pathol Int; 1999 Oct; 49(10):898-902. PubMed ID: 10571824
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin-related hereditary amyloid polyneuropathy presenting with large fibre involvement and cardiomyopathy.
Cruz S; Cortes-Vicente E; Illa I; Rojas-Garcia R
Amyloid; 2016; 23(1):64-5. PubMed ID: 26806028
[No Abstract] [Full Text] [Related]
5. Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases.
Cruz MW; Schmidt H; Botteman MF; Carter JA; Chopra AS; Stewart M; Hopps M; Fallet S; Amass L
Amyloid; 2017 Mar; 24(sup1):109-110. PubMed ID: 28434345
[No Abstract] [Full Text] [Related]
6. Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTR
Benson MD; Ackermann EJ; Monia BP
Amyloid; 2017 Mar; 24(sup1):134-135. PubMed ID: 28434337
[No Abstract] [Full Text] [Related]
7. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
[TBL] [Abstract][Full Text] [Related]
8. Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin.
Cassereau J; Lavigne C; Letournel F; Ghali A; Verny C; Dubas F; Devière F; Nicolas G
J Peripher Nerv Syst; 2008 Sep; 13(3):251-4. PubMed ID: 18844793
[No Abstract] [Full Text] [Related]
9. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
Wixner J; Pilebro B; Lundgren HE; Olsson M; Anan I
Amyloid; 2017 Mar; 24(sup1):78-79. PubMed ID: 28042702
[No Abstract] [Full Text] [Related]
10. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
García-Herola A; Prieto M; Pascual S; Berenguer M; López-Viedma B; Mir J; Vilchez JJ; Berenguer J
Liver Transpl Surg; 1999 May; 5(3):246-8. PubMed ID: 10226117
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
Ripoll-Vera T; Buades J; Cisneros E; Gómez Y; Núñez J; Raya M
Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
[No Abstract] [Full Text] [Related]
12. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
[TBL] [Abstract][Full Text] [Related]
13. Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).
Nakase T; Yamashita T; Matsuo Y; Nomura T; Sasada K; Masuda T; Misumi Y; Takamatsu K; Oda S; Furukawa Y; Obayashi K; Matsui H; Ando Y; Ueda M
Intern Med; 2019 Sep; 58(18):2695-2698. PubMed ID: 31178489
[TBL] [Abstract][Full Text] [Related]
14. Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
Di Bella G; Minutoli F
Amyloid; 2018 Jun; 25(2):135. PubMed ID: 29523040
[No Abstract] [Full Text] [Related]
15. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
[No Abstract] [Full Text] [Related]
16. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
Masuda T; Ueda M; Suenaga G; Misumi Y; Tasaki M; Izaki A; Yanagisawa Y; Inoue Y; Motokawa H; Matsumoto S; Mizukami M; Arimura A; Deguchi T; Nishio Y; Yamashita T; Inomata Y; Obayashi K; Ando Y
Neurology; 2017 Jun; 88(23):2192-2197. PubMed ID: 28490654
[TBL] [Abstract][Full Text] [Related]
17. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348
[No Abstract] [Full Text] [Related]
18. A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family.
Hellman U; Lundgren HE; Westermark P; Stafberg C; Nahi H; Tachlinski S; Guggi M; Flogegård M; Hamid M; Escher SA; Suhr OB
Eur J Med Genet; 2015 Apr; 58(4):211-5. PubMed ID: 25721874
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.
Hellman U; Lång K; Ihse E; Jonasson J; Olsson M; Lundgren HE; Pilebro B; Westermark P; Wixner J; Anan I
Scand J Clin Lab Invest; 2019 Oct; 79(6):372-376. PubMed ID: 31169435
[TBL] [Abstract][Full Text] [Related]
20. Response: Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
Henein MY; Lindqvist P
Amyloid; 2018 Jun; 25(2):136. PubMed ID: 29529882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
